A cellular automata model of tumor-immune system interactions

Journal of Theoretical Biology

Volumn 239, Issue 3, 2006, Pages 334-350

  Mallet, D G ^a,b   De Pillis, L G ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b HARVEY MUDD COLLEGE   (United States)

Author keywords

Cellular automata; Immune; Lymphocyte infiltration; Oscillatory growth; Tumor

Indexed keywords

TUMOR;

ARTICLE; CELL COUNT; CELL DEATH; CELL METABOLISM; CELL MIGRATION; CYTOLYSIS; IMMUNOCOMPETENT CELL; LYMPHOCYTIC INFILTRATION; MATHEMATICAL MODEL; PRIORITY JOURNAL; SIMULATION; TUMOR GROWTH; TUMOR IMMUNITY;

CELL CYCLE; CELL DIVISION; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LEUKEMIC INFILTRATION; MODELS, IMMUNOLOGICAL; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33644890522     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2005.08.002     Document Type: Article

References (76)

1. J.A. Adam, and N. Bellomo A Survey of Models for Tumor-immune System Dynamics 1997 Birkhauser Basel
2. T. Alarcon, H.M. Byrne, and P.K. Maini A cellular automaton model for tumour growth in inhomogeneous environment J. Theor. Biol. 225 2003 257 274
3. A.R.A. Anderson, and M.A.J. Chaplain Continuous and discrete mathematical models of tumor induced angiogenesis Bull. Math. Biol. 60 1998 877 900
4. R.P. Araujo, and D.L.S. McElwain A history of the study of solid tumour growth: the contribution of mathematical modelling Bull. Math. Biol. 66 2004 1039 1091
5. J.C. Arciero, T.L. Jackson, and D.E. Kirschner A mathematical model of tumor-immune evasion and siRNA treatment Discrete Continuous Dynamical Systems - Ser. B 4 1 2004 39 58
6. G. Bard Ermentrout, and L. Edelstein-Keshet Cellular automata approaches to biological modeling J. Theor. Biol. 160 1993 97 133
7. N. Bellomo, and N. Preziosi Modelling and mathematical problems related to tumor evolution and its interaction with the immune system Math. Comput. Modelling 32 2000 413 452
8. N. Bellomo, B. Firmani, and L. Guerri Bifurcation analysis for a nonlinear system of integro-differential equations modelling tumor-immune cells competition Appl. Math. Lett. 12 1999 39 44
9. J.N. Blattman, and P.D. Greeberg Cancer immunotherapy: a treatment for the masses Science 205 2004 200 205
10. T. Burden, J. Ernstberger, and K. Renee Fister Optimal control applied to immunotherapy Discrete Continuous Dynamical Systems - Ser. B 4 1 2004 135 146
11. A.C. Burton Rate of growth of solid tumours as a problem of diffusion Growth 30 1966 159 176
12. H.M. Byrne The importance of intercellular adhesion in the development of carcinomas IMA J. Math. Appl. Med. Biol. 305323 1997 14
13. Byrne, H.M., 1999. Using mathematics to study solid tumour growth. In: Proceedings of the Ninth General Meetings of European Women in Mathematics, pp. 81-107.
14. H.M. Byrne, and M.A.J. Chaplain Growth of nonnecrotic tumours in the presence and absence of inhibitors Math. Biosci. 151181 1995 130
15. H.M. Byrne, and M.A.J. Chaplain Modelling the role of cell-cell adhesion in the growth and development of carcinomas Math. Comput. Modell. 24 12 1996 1 17
16. H.M. Byrne, and M.A.J. Chaplain Free boundary value problems associated with the growth and development of multicellular spheroids Eur. J. Appl. Math. 8 1997 639 658
17. D.M. Callewaert, P. Meyers, J. Hiernaux, and G. Radcliff Kinetics of cellular cytotoxicity mediated by cloned cytotoxic T lymphocytes Immunobiology 178 1988 203 214
18. Cerwenker, A., Lanier, L.L., 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. October, 41-48.
19. J. Couzin Select T cells, given space, shrink tumors Science 297 2002 1973
20. J. Donnelly Cancer vaccine targets leukemia Nat. Med. 9 11 2003 1354 1356
21. S. Dormann, and A. Deutsch Modeling of self-organized avascular tumor growth with a hybrid cellular automaton In: Silico Biol. 2 2002 0035
22. Drasdo, D., Loeffler, M., 2001. Individual-based models on growth and folding in one-layered tissues: intestinal crypts and early development. Nonlinear Anal. 47, 245-256.
23. M.E. Dudley, and J.R. Wunderlich Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 5594 2002 850 854
24. Encyclopædia Britannica. 2004. Cell. Encyclopædia Britannica Online. [Online] http://search.eb.com/eb/article?tocId=9106125.
25. S.C. Ferreira Jr., M.L. Martins, and M.J. Vilela Reaction-diffusion model for the growth of avascular tumor Phys. Rev. E 65 2002 021907
26. S.C. Ferreira Jr., M.L. Martins, and M.J. Vilela Morphology transitions induced by chemotherapy in carcinomas in situ Phys. Rev. E 67 2003 051914
27. J. Folkman, and M. Hochberg Self-regulation of growth in three dimensions J. Exp. Med. 138 1973 745 753
28. S.J. Franks, H.M. Byrne, J.R. King, J.C.E. Underwood, and C.E. Lewis Modelling the early growth of ductal carcinoma in situ J. Math. Biol. 47 2003 424 452
29. S.J. Franks, H.M. Byrne, H. Mudhar, J.C.E. Underwood, and C.E. Lewis Modelling the growth of comedo ductal carcinoma in situ Math. Med. Biol. 20 2003 277 308
30. S.J. Franks, H.M. Byrne, J.C.E. Underwood, and C.E. Lewis Biological inferences from a mathematical model of comedo ductal carcinoma in situ of the breast J. Theor. Biol. 232 4 2005 523 543
31. M. Galach Dynamics of the tumor-immune system competition - the effect of time delay Int. J. Appl. Math. Comput. Sci. 13 3 2003 395 406
32. Galle, J., Loeffler, M., Drasdo, D. Modeling the effect of deregulated proliferation and apoptosis on the growth dynamics of epithelial cell populations in vitro. Biophys. J. 88 (1), 62-75.
33. R.A. Gatenby, and E.T. Gawlinski A reaction-diffusion model of cancer invasion Cancer Res. 56 1996 5745 5753
34. H.P. Greenspan Models for the growth of a solid tumor by diffusion Stud. Appl. Math. 51 1972 317 338
35. A.R. Kansal, S. Torquato, G.R. Harsh IV, E.A. Chiocca, and T.S. Deisboeck Simulated brain tumor growth dynamics using a three dimensional cellular automaton J. Theor. Biol. 203 2000 367 382
36. D. Kirschner, and J.C. Panetta Modeling immunotherapy of the tumor-immune interaction J. Math. Biol. 37 1998 235 252
37. Kleinsmith, L.J., Kerrigan, D., Spangler, S., 2001. National cancer institute: Science behind the news - understanding cancer. [Online] http://press2.nci.nih.gov/sciencebehind/cancer/cancer01.htm
38. J.G. Krikorian, C.S. Portlock, D.P. Cooney, and S.A. Rosenberg Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases Cancer 46 1980 2093 2099
39. V.A. Kuznetsov Basic models of tumor-immune system interactions - identification, analysis and predictions J.A. Adam N. Bellomo A Survey of Models for Tumor-immune System Dynamics 1997 Birkhauser Basel
40. V. Kuznetsov, and G. Knott Modelling tumor regrowth and immunotherapy Math. Comput. Modell. 33 12/13 2001 1275 1287
41. A. Lin A model of tumor and lymphocyte interactions Discrete Continuous Dynam. Systems - Ser. B 4 1 2004 241 266
42. Mallet, D.G., 2004. Mathematical modeling of the role of haptotaxis in tumour growth and invasion. Ph.D. Thesis, Queensland University of Technology, Brisbane, Australia.
43. The Mathworks, Inc., 2002. MATLAB Release 13. Natick, MA.
44. A. Matzavinos, and M.A.J. Chaplain Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour Math. Med. Biol. 21 2004 134
45. S.R. McDougal, A.R.A. Anderson, M.A.J. Chaplain, and J.A. Sheraratt Mathematical modelling of flow through vascular networks: implication for tumour-induced angiogenesis and chemotherapy strategies Bull. Math. Biol. 64 2002 673702
46. S.J. Merrill Foundations of the use of enzyme kinetic analogy in cell-mediated cytotoxicity Math. Biosci. 62 1982 219 236
47. M.R. Owen, and J.A. Sherratt Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interactions J. Theor. Biol. 189 1 1997 63 80
48. M.R. Owen, and J.A. Sherratt Modelling the macrophage invasion of tumours: effects on growth and composition IMA J. Math. Appl. Med. Biol. 15 1998 165 185
49. M.R. Owen, and J.A. Sherratt Mathematical modelling of macrophage dynamics in tumours Math. Models Methods Appl. Sci. 9 4 1999 513 539
50. M.R. Owen, H.M. Byrne, and C.E. Lewis Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites J. Theor. Biol. 226 4 2004 377 391
51. D.M. Pardoll Cancer vaccines Nat. Med. Vaccine 4 5(Suppl.) 1998 525 531
52. A.A. Patel, E.T. Gawlinski, S.K. Lemiueux, and R.A. Gatenby A cellular automaton model of early tumor growth and invasion: the effects of native tissue vascularity and increased anaerobic tumor metabolism J. Theor. Biol. 213 2001 315 331
53. Paul, W.E., 2003. Fundamental Immunology, fifth ed. Lippincott, Williams & Wilkins Publishers, Philadelphia, PA.
54. A.S. Perelson, and C.A. Mackean Kinetics of cell-mediated cytotoxicity: stochastic and deterministic multistage models J. Math. Bio. 170 1984 161 194
55. A.S. Perelson, and G. Weisbuch Immunology for physicists Rev. Mod. Phys. 69 4 1997 1219 1267
56. G.J. Pettet, C.P. Please, M.J. Tindall, and D.L.S. McElwain The migration of cells in multicell tumor spheroids Bull. Math. Biol. 63 2001 231 257
57. L. de Pillis, and A. Radunskaya A mathematical tumor model with immune resistance and drug therapy: an optimal control approach J. Theor. Med. 3 2001 79 100
58. de Pillis, L.G., Radunskaya, A., 2003a. A mathematical model of immune response to tumor invasion. In: Bathe, K.J. (Ed.), Proceedings of the Second MIT Conference on Computational Fluid and Solid Mechanics, Computational Fluid and Solid Mechanics.
59. L.G. de Pillis, and A. Radunskaya The dynamics of an optimally controlled tumor model: a case study Math. Comput. Modell. 37 2003 1221 1244
60. C.P. Please, G.J. Pettet, and D.L.S. McElwain Avascular tumour dynamics and necrosis Math. Models Methods Appl. Sci. 9 1999 569 580
61. Preziosi, L. (Ed.), 2003. Cancer Modelling and Simulation. Taylor & Francis Ltd., Chapman & Hall/CRC, London, Boca Raton, FL.
62. H. Riedel Models for tumour growth and differentiations M.R. Alison The Cancer Handbook 2004 Wiley New York
63. S.A. Rosenberg, J.C. Yang, P.F. Robbins, J.R. Wunderlich, P. Hwu, and R.M. Sherry Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma J. Immunother. 26 5 2003 385 393
64. S.A. Rosenberg, J.C. Yang, and N.P. Restifo Cancer immunotherapy: moving beyond current vaccines Nat. Med. 10 9 2004 909 915
65. J.C. Schmollinger, R.H. Vonderhelde, and K.M. Hoar Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction Proc. Natl Acad. Sci. USA 100 6 2003 3398 3403
66. P.E. Seiden, and F. Celada A model for simulating cognate recognition and response in the immune system J. Theor. Biol. 158 3 1992 328 357
67. Smallbone, K., Gavaghan, D.J., et al., 2005. The role of acidity in solid tumour growth and invasion. J. Theor. Biol. 235 (4), 476-485.
68. R. Soiffer, T. Lynch, and M. Mihm Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma Proc. Natl Acad. Sci. USA 95 1998 13,141 13,146
69. R.M. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model Science 240 1988 177 184
70. T. Takayanagi, and A. Ohuchi A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes Microbiol. Immunol. 45 1 2001 709 715
71. J.P. Ward, and J.R. King Mathematical modelling of avascular-tumour growth IMA J. Math. Appl. Med. Biol. 14 1997 3969
72. J.P. Ward, and J.R. King Mathematical modelling of avascular-tumour growth - II. Modelling growth saturation IMA J. Math. Appl. Med. Biol. 16 1999 171211
73. R.A. Weinberg How cancer arises Sci. Am. 275 3 1996 62
74. C.J. Wheeler, and D. Asha Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination Clin. Cancer Res. 10 2004 5316 5326
75. Y. Xu A free boundary problem model of ductal carcinoma in situ Discrete Continuous Dynam. B 4 1 2004 337 348
76. L. Zhang, J.R. Conejo-Garcia, and D. Katsaros Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N. Eng. J. Med. 348 3 2003 203 213